Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001223 · ClinicalTrials.gov registry record
Diagnosis and Treatment of Patients With Cystic Fibrosis
A clinical trial, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Terminated
- Registry status
- 79
- Enrollment target
NCT00001223 is a clinical trial that was terminated before completion, run by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). The registered enrollment target is 79 participants.
The verdict
NCT00001223 was terminated before completion, sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- TERMINATED
- Registry status
- 79 participants
- Enrollment target
Study Summary
This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (genotypes) of cystic fibrosis.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 1988-01-01 |
| Est. Completion | 2026-01-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00001223
The ClinicalTrials.gov registry entry for NCT00001223 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00001223 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00001223 about?
NCT00001223 is a clinical study titled "Diagnosis and Treatment of Patients With Cystic Fibrosis". This is an omnibus protocol for studying patients with cystic fibrosis. The main purpose of the study is to obtain samples and data collected during standard clinical care for future research to expand knowledge of the natural history, clinical manifestations (phenotypes) and the genetic variants (g...
What is the current status of trial NCT00001223?
This trial is currently terminated. The enrollment target is 79 participants. The study started on 1988-01-01. Estimated completion is 2026-01-30.
Who is sponsoring clinical trial NCT00001223?
This trial is sponsored by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), which has 490 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.